SE502644C2 - Vasoaktiva vasotocinderivat - Google Patents

Vasoaktiva vasotocinderivat

Info

Publication number
SE502644C2
SE502644C2 SE9000691A SE9000691A SE502644C2 SE 502644 C2 SE502644 C2 SE 502644C2 SE 9000691 A SE9000691 A SE 9000691A SE 9000691 A SE9000691 A SE 9000691A SE 502644 C2 SE502644 C2 SE 502644C2
Authority
SE
Sweden
Prior art keywords
hmp
vasotocin
hgn
derivatives
vasotocin derivatives
Prior art date
Application number
SE9000691A
Other languages
English (en)
Swedish (sv)
Other versions
SE9000691D0 (sv
SE9000691L (sv
Inventor
Carl-Johan Aurell
Per Melin
Anders Nilsson
Jerzy Trojnar
Original Assignee
Ferring Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Ab filed Critical Ferring Ab
Priority to SE9000691A priority Critical patent/SE502644C2/sv
Publication of SE9000691D0 publication Critical patent/SE9000691D0/xx
Priority to IL9729891A priority patent/IL97298A/en
Priority to IE64891A priority patent/IE62345B1/en
Priority to ES91905375T priority patent/ES2089196T3/es
Priority to PCT/SE1991/000154 priority patent/WO1991013092A1/en
Priority to EP91905375A priority patent/EP0517778B1/en
Priority to HU9202748A priority patent/HU215121B/hu
Priority to MC91SE9100154D priority patent/MC2254A1/xx
Priority to US07/923,895 priority patent/US5459236A/en
Priority to DE69119409T priority patent/DE69119409T2/de
Priority to CA002076749A priority patent/CA2076749C/en
Priority to DK91905375.1T priority patent/DK0517778T3/da
Priority to AT91905375T priority patent/ATE137764T1/de
Priority to JP3505030A priority patent/JP2957275B2/ja
Priority to SU5052869/04A priority patent/RU2067586C1/ru
Priority to KR1019920702039A priority patent/KR0171614B1/ko
Priority to AU73424/91A priority patent/AU633198B2/en
Publication of SE9000691L publication Critical patent/SE9000691L/
Priority to NO92923333A priority patent/NO923333L/no
Priority to FI923820A priority patent/FI109703B/fi
Publication of SE502644C2 publication Critical patent/SE502644C2/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
SE9000691A 1990-02-27 1990-02-27 Vasoaktiva vasotocinderivat SE502644C2 (sv)

Priority Applications (19)

Application Number Priority Date Filing Date Title
SE9000691A SE502644C2 (sv) 1990-02-27 1990-02-27 Vasoaktiva vasotocinderivat
IL9729891A IL97298A (en) 1990-02-27 1991-02-20 History and vasotoxin and azo activity and pharmaceutical preparations containing them
AU73424/91A AU633198B2 (en) 1990-02-27 1991-02-26 Vasoactive vasotocin derivatives
US07/923,895 US5459236A (en) 1990-02-27 1991-02-26 Vasoactive vasotocin derivatives
DK91905375.1T DK0517778T3 (da) 1990-02-27 1991-02-26 Vasoaktive vasotocinderivater
PCT/SE1991/000154 WO1991013092A1 (en) 1990-02-27 1991-02-26 Vasoactive vasotocin derivatives
EP91905375A EP0517778B1 (en) 1990-02-27 1991-02-26 Vasoactive vasotocin derivatives
HU9202748A HU215121B (hu) 1990-02-27 1991-02-26 Eljárás vazotocinszármazékok és ilyen vegyületeket tartalmazó gyógyászati készítmények előállítására
MC91SE9100154D MC2254A1 (fr) 1990-02-27 1991-02-26 Derives de la vasotocine
IE64891A IE62345B1 (en) 1990-02-27 1991-02-26 Vasoactive vasotocin derivatives
DE69119409T DE69119409T2 (de) 1990-02-27 1991-02-26 Vasoaktive derivate des vasotocins
CA002076749A CA2076749C (en) 1990-02-27 1991-02-26 Vasoactive vasotocin derivatives
ES91905375T ES2089196T3 (es) 1990-02-27 1991-02-26 Derivados de la vasotocina vasoactiva.
AT91905375T ATE137764T1 (de) 1990-02-27 1991-02-26 Vasoaktive derivate des vasotocins
JP3505030A JP2957275B2 (ja) 1990-02-27 1991-02-26 血管作動性バソトシン誘導体
SU5052869/04A RU2067586C1 (ru) 1990-02-27 1991-02-26 Производные вазотоцина
KR1019920702039A KR0171614B1 (ko) 1990-02-27 1991-02-26 혈관활성 바소토신 유도체
FI923820A FI109703B (fi) 1990-02-27 1992-08-26 Menetelmä vasoaktiivisten vasotosiinijohdannaisten valmistamiseksi
NO92923333A NO923333L (no) 1990-02-27 1992-08-26 Vasoaktive vasotocinderivater

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9000691A SE502644C2 (sv) 1990-02-27 1990-02-27 Vasoaktiva vasotocinderivat

Publications (3)

Publication Number Publication Date
SE9000691D0 SE9000691D0 (sv) 1990-02-27
SE9000691L SE9000691L (sv) 1991-08-28
SE502644C2 true SE502644C2 (sv) 1995-11-27

Family

ID=20378692

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9000691A SE502644C2 (sv) 1990-02-27 1990-02-27 Vasoaktiva vasotocinderivat

Country Status (19)

Country Link
US (1) US5459236A (ja)
EP (1) EP0517778B1 (ja)
JP (1) JP2957275B2 (ja)
KR (1) KR0171614B1 (ja)
AT (1) ATE137764T1 (ja)
AU (1) AU633198B2 (ja)
CA (1) CA2076749C (ja)
DE (1) DE69119409T2 (ja)
DK (1) DK0517778T3 (ja)
ES (1) ES2089196T3 (ja)
FI (1) FI109703B (ja)
HU (1) HU215121B (ja)
IE (1) IE62345B1 (ja)
IL (1) IL97298A (ja)
MC (1) MC2254A1 (ja)
NO (1) NO923333L (ja)
RU (1) RU2067586C1 (ja)
SE (1) SE502644C2 (ja)
WO (1) WO1991013092A1 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
PT710243E (pt) * 1993-06-29 2000-11-30 Ferring Bv Sintese melhorada de peptidos ciclicos.
JO2937B1 (en) * 2004-08-11 2016-03-15 فيرينغ.بي.في Tight muscles of the peptide vascular tensioner receptor
US8883965B2 (en) 2006-02-10 2014-11-11 Ferring B.V. Compounds
US9050286B2 (en) * 2007-08-14 2015-06-09 Ferring B.V. Use of peptidic vasopression receptor agonists
RU2454426C1 (ru) * 2011-04-06 2012-06-27 Федеральное государственное образовательное учреждение высшего профессионального образования Санкт-Петербургский государственный университет Пептид калий-уретический
KR101304427B1 (ko) 2011-04-12 2013-09-05 한국과학기술연구원 재사용이 용이한 기공체 - 위성 나노입자 복합체 및 그 제조방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1246055A (en) * 1980-03-24 1988-12-06 Joseph H. Cort N-.omega.-substituted hormonogens of vasopressin and its synthetic analogs
SE469473B (sv) * 1987-10-07 1993-07-12 Ferring Ab Vasoaktiva peptider

Also Published As

Publication number Publication date
WO1991013092A1 (en) 1991-09-05
NO923333D0 (no) 1992-08-26
FI109703B (fi) 2002-09-30
FI923820A0 (fi) 1992-08-26
CA2076749C (en) 2001-02-20
AU633198B2 (en) 1993-01-21
ES2089196T3 (es) 1996-10-01
EP0517778A1 (en) 1992-12-16
HUT61580A (en) 1993-01-28
US5459236A (en) 1995-10-17
SE9000691D0 (sv) 1990-02-27
IE62345B1 (en) 1995-01-25
DK0517778T3 (da) 1996-08-19
IL97298A (en) 1995-08-31
IE910648A1 (en) 1991-08-28
HU215121B (hu) 1998-09-28
AU7342491A (en) 1991-09-18
CA2076749A1 (en) 1991-08-28
JP2957275B2 (ja) 1999-10-04
NO923333L (no) 1992-10-16
DE69119409D1 (de) 1996-06-13
MC2254A1 (fr) 1993-03-25
JPH05504575A (ja) 1993-07-15
FI923820A (fi) 1992-08-26
ATE137764T1 (de) 1996-05-15
RU2067586C1 (ru) 1996-10-10
KR920703003A (ko) 1992-12-17
DE69119409T2 (de) 1996-09-05
HU9202748D0 (en) 1992-12-28
KR0171614B1 (ko) 1999-02-01
SE9000691L (sv) 1991-08-28
EP0517778B1 (en) 1996-05-08
IL97298A0 (en) 1992-05-25

Similar Documents

Publication Publication Date Title
US4766108A (en) Tyr-Arg-vasopressin antagonists
US5106834A (en) Linear free-sulfhydryl-containing oligopeptide derivatives as antihypertensive agents
US5410019A (en) Therapeutic peptides
US4724229A (en) Arg-arg-arg-vasopressin antagonists
SE502644C2 (sv) Vasoaktiva vasotocinderivat
EP0438566B1 (en) Substance P antagonists
US4481194A (en) Des-proline-des-glycine vasopressin antagonists
US4481193A (en) Des-proline vasopressin antagonists
US4597901A (en) β-indolylalanyl or β-indolylglycinyl vasopressin antagonists
EP0380554B1 (en) Vasoactive peptides
US4876243A (en) Vasopressin compounds
US4719199A (en) Diuretic compositions and methods of producing diuresis
CA1249397A (en) Process for preparing des-proline vasopressin antagonists
Derdowska et al. Influence of enantiomers of 1-naphthylalanine in position 2 of VAVP and dVAVP on their pharmacological properties
US4684716A (en) Polypeptide intermediates
US4826813A (en) 4'-Methyl-β-mercapto-β,β-cyclopentamethylenepropionic acid vasopressin antagonists
Manning et al. Effects of a D-Cys6/L-Cys6 interchange in nonselective and selective vasopressin and oxytocin antagonists
EP0346068A2 (en) D-Cys6 vasopressin antagonists
JPS63225399A (ja) ペプチド誘導体およびその製造法
Gobbo et al. Synthesis and biological activities of head‐to‐tail cyclic bradykinin analogues of varying ring size
EP0234935A2 (en) Vasopressin compounds
JPH03128395A (ja) ８―ｄ―ホモアルギニンバソプレッシン類似体

Legal Events

Date Code Title Description
NUG Patent has lapsed